Targeting the TREK-1 potassium channel via riluzole to eliminate the neuropathic and depressive-like effects of oxaliplatinLaura Poupon, Jérôme Busserolles, Vanessa Pereira et al.|Neuropharmacology|2018Cited by 70
New Insight in Cold Pain: Role of Ion Channels, Modulation, and Clinical PerspectivesStéphane Lolignier, Jérôme Busserolles, Enrico Leipold et al.|Journal of Neuroscience|2016Cited by 69
Prevalence of Chemotherapy-Induced Peripheral Neuropathy in Multiple Myeloma Patients and its Impact on Quality of Life: A Single Center Cross-Sectional StudyMarie Selvy, David Balayssac, Nicolas Kerckhove et al.|Frontiers in Pharmacology|2021Cited by 53
Relation between auditory difficulties and bortezomib-induced peripheral neuropathy in multiple myeloma: a single-center cross-sectional studyFabrice Giraudet, David Balayssac, Marie Selvy et al.|European Archives of Oto-Rhino-Laryngology|2022Cited by 7
Chemotherapy-Induced Peripheral Neuropathy and New Therapeutic Targets: Preclinical Data of Drug RepositioningDavid Balayssac, Jérôme Busserolles, Aurore Collin et al.|Douleur et Analgésie|2022Cited by 0